Evidence check: HbA1c in the context of allergy

The combination of HbA1c (long-term blood glucose) with allergies lacks strong scientific evidence. HbA1c is a well-established marker for average glucose over 2–3 months, primarily used for diabetes diagnosis and monitoring. Some observational studies suggest a link between elevated HbA1c and allergic conditions like asthma or atopic dermatitis, possibly via inflammatory pathways or insulin resistance. However, the evidence is mostly mechanistic and insufficient for clinical recommendations. Direct-to-consumer tests that include HbA1c in an allergy context often overstate its predictive value. HbA1c levels are influenced by many factors (e.g., anemia, kidney function, ethnicity), complicating interpretation. Without medical guidance and consideration of lifestyle, diet, and inflammation status, the utility for allergy patients remains questionable. Evidence grade: unclear/mechanistic. No specific sources from the provided context.